Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Cancer Therapeutics

• Publication date

  2012-03-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1535-7163.MCT-12-0066PMID 22389469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

  2011cited by this paper
• Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics.

  2011cited by this paper
• SCFFBW 7 regulates cellular apoptosis by targeting MCL 1 for ubiquitylation and destruction

  2011cited by this paper
• High Expression of H3K27me3 in Human Hepatocellular Carcinomas Correlates Closely with Vascular Invasion and Predicts Worse Prognosis in Patients

  2011cited by this paper
• The nontoxic natural compound Curcumin exerts anti-proliferative, anti-migratory, and anti-invasive properties against malignant gliomas

  2010cited by this paper
• SCFFbw7 Regulates Cellular Apoptosis By Targeting Mcl-1 for Ubiquitination and Destruction

  2010cited by this paper
• The Fbw7 tumor suppressor targets KLF5 for ubiquitin-mediated degradation and suppresses breast cell proliferation.

  2010cited by this paper
• p53-Independent Induction of G1 Arrest and p21WAF1/CIP1 Expression by Ascofuranone, an Isoprenoid Antibiotic, through Downregulation of c-Myc

  2010cited by this paper
• Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc

  2010cited by this paper
• The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation

  2010cited by this paper
• Myc roles in hematopoiesis and leukemia.

  2010cited by this paper
• Mechanisms of c-Myc Degradation by Nickel Compounds and Hypoxia

  2009cited by this paper
• Targeting the ubiquitin system in cancer therapy

  2009cited by this paper
• Hematopoietic Stem Cell Differentiation Regulated by a Single Ubiquitin Ligase: Substrate Complex

  2009cited by this paper
• Widespread microRNA repression by Myc contributes to tumorigenesis

  2008cited by this paper
• Modelling Myc inhibition as a cancer therapy

  2008cited by this paper
• E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer.

  2008cited by this paper
• MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.

  2008cited by this paper
• FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation

  2008cited by this paper
• FBXW7 Targets mTOR for Degradation and Cooperates with PTEN in Tumor Suppression

  2008cited by this paper
• FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors

  2007cited by this paper
• Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis

  2007cited by this paper
• Oridonin, a diterpenoid extracted from medicinal herbs, targets AML1-ETO fusion protein and shows potent antitumor activity with low adverse effects on t(8;21) leukemia in vitro and in vivo.

  2007cited by this paper
• Fbw7 and Usp28 Regulate Myc Protein Stability in Response to DNA Damage

  2007cited by this paper
• The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling.

  2007cited by this paper
• Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells

  2007cited by this paper
• MicroRNA expression profiles for the NCI-60 cancer cell panel

  2007cited by this paper
• The ubiquitin-specific protease USP28 is required for MYC stability

  2007cited by this paper
• The Myc oncoprotein as a therapeutic target for human cancer.

  2006cited by this paper
• Global mapping of c-Myc binding sites and target gene networks in human B cells

  2006cited by this paper
• The immunomodulatory benzodiazepine Bz-423 inhibits B-cell proliferation by targeting c-myc protein for rapid and specific degradation.

  2006cited by this paper
• Aberrant stabilization of c-Myc protein in some lymphoblastic leukemias

  2006cited by this paper
• Novel Mechanism of Inhibition of Nuclear Factor-κB DNA-Binding Activity by Diterpenoids Isolated from Isodon rubescens

  2005cited by this paper
• c-Myc-regulated microRNAs modulate E2F1 expression

  2005cited by this paper
• Oridonin, a diterpenoid purified from Rabdosia rubescens, inhibits the proliferation of cells from lymphoid malignancies in association with blockade of the NF-κB signal pathways

  2005cited by this paper
• [Regulation of telomerase activity and cell cycle of K562 cells by oridonin].

  2004cited by this paper
• The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation

  2004cited by this paper
• Phosphorylation‐dependent degradation of c‐Myc is mediated by the F‐box protein Fbw7

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004influential reference
• Genomic targets of the human c-Myc protein.

  2003cited by this paper
• A microRNA array reveals extensive regulation of microRNAs during brain development.

  2003cited by this paper
• hCDC4b, a regulator of cyclin E, as a direct transcriptional target of p53

  2003cited by this paper
• Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells.

  2003cited by this paper
• The proto-oncogene c-myc in hematopoietic development and leukemogenesis

  2002cited by this paper
• Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase

  2001cited by this paper
• Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line

  2001cited by this paper
• Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability.

  2000cited by this paper
• The role of c-myc in cell growth.

  1993cited by this paper
• Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis.

  1991cited by this paper
• Antitumor activity of the isodon diterpenoids: Structural requirements for the activity

  1976cited by this paper

• Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities

  2025cites this paper
• Oridonin induces ferroptosis by inhibiting ubiquitin-mediated degradation of HMOX1 in hepatocellular carcinoma.

  2025cites this paper
• E3 Ubiquitin ligases Cbl-b and c-Cbl maintain the homeostasis of macrophages by regulating the M-CSF/M-CSFR signaling axis

  2025cites this paper
• A patent review of SCF E3 ligases inhibitors for cancer：Structural design, pharmacological activities and structure-activity relationship.

  2024cites this paper
• Ubiquitination of NS1 Confers Differential Adaptation of Zika Virus in Mammalian Hosts and Mosquito Vectors

  2024cites this paper
• The Relationship between Circadian Rhythm and Cancer Disease

  2024cites this paper
• Research and Development Progression of Oridonin for Hematological Malignancies Therapy.

  2024cites this paper
• The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer

  2024cites this paper
• Oridonin from Rabdosia rubescens: An emerging potential in cancer therapy – A comprehensive review

  2024cites this paper
• Organelle resolved proteomics uncovers PLA2R1 as a novel cell surface marker required for chordoma growth

  2024cites this paper
• Therapeutic approaches targeting oncogenic proteins in myeloid leukemia: challenges and perspectives

  2024cites this paper
• Role for the F-box Proteins in Heart Diseases.

  2024cites this paper
• Suppression of Cancer Cell Stemness and Drug Resistance via MYC Destabilization by Deubiquitinase USP45 Inhibition with a Natural Small Molecule

  2023cites this paper
• Drugs targeting the particle for arrangement of quaternary structure (PAQosome) and protein complex assembly

  2023cites this paper
• Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers

  2023cites this paper
• Ubiquitination Links DNA Damage and Repair Signaling to Cancer Metabolism

  2023cites this paper
• Targeting Myc-driven stress addiction in colorectal cancer.

  2023cites this paper
• The roles of E3 ubiquitin ligases in cancer progression and targeted therapy

  2023cites this paper
• The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy

  2023cites this paper
• [Juglone induces proliferation inhibition and apoptosis of cervical cancer cells via promoting c-Myc ubiquitination].

  2022cites this paper
• Recent advances in the pharmacological targeting of ubiquitin-regulating enzymes in cancer.

  2022cites this paper
• Time to fight: targeting the circadian clock molecular machinery in cancer therapy.

  2021cites this paper
• Therapeutic targeting of “undruggable” MYC

  2021cites this paper
• Fate of hematopoietic stem cells determined by Notch1 signaling (Review)

  2021cites this paper
• ThermomiR-377-3p-induced suppression of Cirbp expression is required for effective elimination of cancer cells and cancer stem-like cells by hyperthermia

  2021cites this paper
• MYC inhibitors in multiple myeloma

  2021cites this paper
• CRISPR/Cas9 screen for genome-wide interrogation of essential MYC binding sites in cancer cells

  2021cites this paper
• Targeting the Ubiquitin-Proteasome System for Cancer Therapeutics by Small-Molecule Inhibitors

  2021cites this paper
• The long journey to bring a Myc inhibitor to the clinic

  2021cites this paper
• The deubiquitinase USP38 promotes cell proliferation through stabilizing c-Myc.

  2021cites this paper
• Circadian rhythm genes in cancer: insight into their functions and regulation involving noncoding RNAs

  2021cites this paper
• The FBXW7‐NOTCH interactome: A ubiquitin proteasomal system‐induced crosstalk modulating oncogenic transformation in human tissues

  2021cites this paper
• Ubiquitination of Nonhistone Proteins in Cancer Development and Treatment

  2021cites this paper
• Oridonin interrupts cellular bioenergetics to suppress glioma cell growth by down‐regulating PCK2

  2021cites this paper
• TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation

  2020cites this paper
• The role of ubiquitination in tumorigenesis and targeted drug discovery

  2020cites this paper
• F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects

  2020cites this paper
• Targeting GSK3 and Associated Signaling Pathways Involved in Cancer

  2020cites this paper
• F-Box Proteins and Cancer

  2020cites this paper
• Novel c-Myc–Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells

  2020cites this paper
• Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics

  2020cites this paper
• [Targeting Cullin-RING E3 ligases for anti-cancer therapy: efforts on drug discovery].

  2020cites this paper
• Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance

  2020cites this paper
• Ubiquitination in cancer stem cell: roles and targeted cancer therapy

  2020cites this paper
• FBW7 Inhibits Myeloid Differentiation in Acute Myeloid Leukemia via GSK3-Dependent Ubiquitination of PU.1

  2020cites this paper
• Expression levels of FBXW7 and MDM2 E3 ubiquitin ligases and their c-Myc and p53 substrates in patients with dysplastic nevi or melanoma

  2020cites this paper
• E3 Ubiquitin Ligases in Cancer and Their Pharmacological Targeting

  2019cites this paper
• FBXW7 in Cancer: What Has Been Unraveled Thus Far?

  2019cites this paper
• Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity.

  2019cites this paper
• Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

  2019cites this paper
• Dictyostelium as model for studying ubiquitination and deubiquitination.

  2019cites this paper
• Xanthohumol, a Prenylated Flavonoid from Hops, Induces Caspase-Dependent Degradation of Oncoprotein BCR-ABL in K562 Cells

  2019cites this paper
• Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment.

  2019cites this paper
• FBW7 loss promotes epithelial-to-mesenchymal transition in non-small cell lung cancer through the stabilization of Snail protein.

  2018cites this paper
• A patent review of the ubiquitin ligase system: 2015–2018

  2018cites this paper
• Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

  2018cites this paper
• miR‐372 and miR‐373 enhance the stemness of colorectal cancer cells by repressing differentiation signaling pathways

  2018cites this paper
• Targeting oncoproteins for degradation by small molecules in myeloid leukemia

  2018cites this paper
• A Novel Diterpenoid Suppresses Osteoclastogenesis and Promotes Osteogenesis by Inhibiting Ifrd1‐Mediated and IκBα‐Mediated p65 Nuclear Translocation

  2018cites this paper
• Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth

  2017cites this paper
• Strategies to Inhibit Myc and Their Clinical Applicability

  2017cites this paper
• Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs

  2017cites this paper
• Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells

  2017cites this paper
• E3 ubiquitin ligases in cancer and implications for therapies

  2017cites this paper
• The Small Molecules Targeting Ubiquitin-Proteasome System for Cancer Therapy.

  2017cites this paper
• Oridonin Induces Apoptosis of Myeloma Cells by Inducing C-Myc Degradation via Nuclear Accumulation of Fbxw 7

  2017cites this paper
• Oridonin increases anticancer effects of lentinan in HepG2 human hepatoblastoma cells.

  2017cites this paper
• Oridonin enhances in vitro anticancer effects of lentinan in SMMC-7721 human hepatoma cells through apoptotic genes.

  2017cites this paper
• Enterovirus 71 protease 2Apro and 3Cpro differentially inhibit the cellular endoplasmic reticulum-associated degradation (ERAD) pathway via distinct mechanisms, and enterovirus 71 hijacks ERAD component p97 to promote its replication

  2017cites this paper
• Oridonin Triggers Chaperon-mediated Proteasomal Degradation of BCR-ABL in Leukemia

  2017cites this paper
• Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system.

  2017cites this paper
• Discovery and development of natural product oridonin-inspired anticancer agents.

  2016cites this paper
• Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer.

  2016cites this paper
• Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells.

  2016cites this paper
• Suppression of c-Myc induces apoptosis via an AMPK/mTOR-dependent pathway by 4-O-methyl-ascochlorin in leukemia cells

  2016cites this paper
• Small molecule therapeutics targeting F-box proteins in cancer.

  2016cites this paper
• Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects.

  2015cites this paper
• Molecular Insight in the Multifunctional Effects of Oridonin

  2015cites this paper
• Overexpression of the long non-coding RNA PVT1 is correlated with leukemic cell proliferation in acute promyelocytic leukemia

  2015cites this paper
• MYC-mediated synthetic lethality for treating tumors.

  2015cites this paper
• Targeting the ubiquitin pathway for cancer treatment.

  2015influential citation
• Constructive innovation of approaching bicyclo[3.2.1]octane in ent-kauranoids

  2015cites this paper
• E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.

  2015cites this paper
• ent-Kaurane-based regio- and stereoselective inverse electron demand hetero-Diels-Alder reactions: synthesis of dihydropyran-fused diterpenoids.

  2014cites this paper
• Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S.

  2014cites this paper
• Oridonin, a promising antitumor natural product in the chemotherapy of hematological malignancies.

  2014cites this paper
• Attacking c-Myc: targeted and combined therapies for cancer.

  2014cites this paper
• Biomimetic Cationic Cyclization toward ent-Kaurene-type Diterpenoids

  2013cites this paper
• Icaritin induces AML cell apoptosis via the MAPK/ERK and PI3K/AKT signal pathways

  2013cites this paper
• Oridonin: targeting programmed cell death pathways as an anti‐tumour agent

  2012cites this paper
• Tumor suppressor functions of FBW7 in cancer development and progression

  2012cites this paper
• Translational repression of cyclin D3 by a stable G-quadruplex in its 5′ UTR: implications for cell cycle regulation

  2012cites this paper